Isracann Biosciences financials at a glance
| Year | Year | 2020 | 2021 | 2022 | 2019 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
C$0.00M | C$0.00M | C$0.00M | C$0.00M | C$0.00M | C$0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
C$0.00 | C$0.00 | ||||
| Div. | Dividends |
|
C$0.00 | C$0.00 | C$0.00 | C$0.00 | C$0.00 | C$0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
108.51m | 135.16m | 146.08m | 0m | 175.99m | 176.73m |
| OCF | Operating Cash Flow |
|
C$-10.40M | C$-4.23M | C$-1.75M | C$-2.94M | C$0.00M | C$0.00M |
| FCF | Free Cash Flow |
|
C$0.00M | C$-4.24M | C$0.00M | C$-3.14M | C$0.00M | C$0.00M |
| FCFS | Free Cash Flow Per Share |
|
C$-0.12 | C$-0.03 | C$-0.01 | C$-0.08 | C$0.00 | C$0.00 |